These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults]. Zawadka M; Lutyńska A Przegl Epidemiol; 2012; 66(1):99-105. PubMed ID: 22708307 [TBL] [Abstract][Full Text] [Related]
4. Research aims to boost pertussis control. Friedrich MJ JAMA; 2011 Jul; 306(1):27-9. PubMed ID: 21730232 [No Abstract] [Full Text] [Related]
5. Immunity to pertussis 5 years after booster immunization during adolescence. Edelman K; He Q; Mäkinen J; Sahlberg A; Haanperä M; Schuerman L; Wolter J; Mertsola J Clin Infect Dis; 2007 May; 44(10):1271-7. PubMed ID: 17443462 [TBL] [Abstract][Full Text] [Related]
6. The role of Bordetella pertussis infections in adults in the epidemiology of pertussis. Cherry JD Dev Biol Stand; 1997; 89():181-6. PubMed ID: 9272350 [TBL] [Abstract][Full Text] [Related]
8. The present and future control of pertussis. Cherry JD Clin Infect Dis; 2010 Sep; 51(6):663-7. PubMed ID: 20704492 [No Abstract] [Full Text] [Related]
9. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Cherry JD Pediatrics; 2005 May; 115(5):1422-7. PubMed ID: 15867059 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395 [TBL] [Abstract][Full Text] [Related]
11. [Pertussis: current epidemiology and recommendations of the Health Council with regard to vaccination policy]. van Wijngaarden JK; Huisman J; van der Meer JW; Visser HK Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2297-301. PubMed ID: 11143295 [TBL] [Abstract][Full Text] [Related]
12. The 2001 serological survey in the Czech Republic--pertussis. Maixnerová M Cent Eur J Public Health; 2003 Dec; 11 Suppl():S17-22. PubMed ID: 15080254 [TBL] [Abstract][Full Text] [Related]
13. Reducing the risk of pertussis in newborn infants. Blangiardi F; Ferrera G J Prev Med Hyg; 2009 Dec; 50(4):206-16. PubMed ID: 20812515 [No Abstract] [Full Text] [Related]
14. Pertussis: acellular, whole-cell, new vaccines, what to choose? Locht C Expert Rev Vaccines; 2016 Jun; 15(6):671-3. PubMed ID: 26938372 [No Abstract] [Full Text] [Related]
15. Pertussis--a disease and vaccine for all ages. Halperin SA N Engl J Med; 2005 Oct; 353(15):1615-7. PubMed ID: 16221785 [No Abstract] [Full Text] [Related]
16. [Assessment of postvaccinal response in children past pertussis]. Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498 [TBL] [Abstract][Full Text] [Related]
17. Pertussis outbreak in northwest Ireland, January - June 2010. Barret AS; Ryan A; Breslin A; Cullen L; Murray A; Grogan J; Bourke S; Cotter S Euro Surveill; 2010 Sep; 15(35):. PubMed ID: 20822735 [TBL] [Abstract][Full Text] [Related]
18. Pertussis: challenges today and for the future. Cherry JD PLoS Pathog; 2013; 9(7):e1003418. PubMed ID: 23935481 [No Abstract] [Full Text] [Related]
19. New whooping cough vaccine for adolescents and adults. FDA Consum; 2005; 39(5):6. PubMed ID: 16421987 [No Abstract] [Full Text] [Related]
20. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease. Cherry JD N Engl J Med; 2012 Aug; 367(9):785-7. PubMed ID: 22894554 [No Abstract] [Full Text] [Related] [Next] [New Search]